Driver in critical condition after Grand Central Parkway crash

NEW YORK, April 18, 2026 /PRNewswire/ — Travel And Tour World (TTW) announces its comprehensive global aviation research for 2026, presenting the Top 50 Airlines in the World, shaping international travel, connectivity, and passenger mobility. The study highlights a transforming…

NEW YORK, April 18, 2026 /PRNewswire/ — As part of Haloid Solutions’ long-term commitment to helping businesses and municipalities acquire critical communications equipment despite budgetary constraints, Haloid now offers specialized financing and leasing programs through its HaloidFLEX program.

NEW YORK, April 18, 2026 /PRNewswire/ — As Earth Day draws global attention to environmental responsibility, Vipboss, a specialist manufacturer and developer of lithium iron phosphate (LiFePO4) battery packs for energy storage and mobility applications, is underscoring its long‑term commitment…

MANASSAS, Va., April 18, 2026 /PRNewswire/ — PureHealth Research now offers a premium collection of lymphatic drainage supplements formulated to assist the body’s natural detoxification processes and help maintain healthy tissue fluid balance. Each product is doctor-approved, naturally sourced, and…

A pair of New York City streets may soon be named for a pair of world-renowned soccer players weeks before the FIFA World Cup finals kick off in the tri-state region — but it would only be temporary.

The mother of a 15-year-old boy gunned down in a Queens park unleashed a vulgarity-laced tirade against his killer and the heartless young people who filmed the deadly violence.  “You are all p—ies,” 33-year-old Shanelle Weston, the mother of 15-year-old

Reading 2 Chronicles 7:11–22, the president joins nearly 500 leaders in a weeklong Bible event honoring America’s 250th, livestreamed on Great American Pure Flix.

SHANGHAI and HONG KONG, April 17, 2026 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological…